Immunovia AB (OSTO:IMMNOV) ROE % Adjusted to Book Value : -14.99% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Immunovia AB ROE % Adjusted to Book Value?

Immunovia AB's ROE % for the quarter that ended in Mar. 2024 was -21.29%. Immunovia AB's PB Ratio for the quarter that ended in Mar. 2024 was 1.42. Immunovia AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -14.99%.

Immunovia AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Immunovia AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunovia AB ROE % Adjusted to Book Value Chart

Immunovia AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-2.83

-6.78

-7.72

-20.33

-165.94

Immunovia AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-113.66	-733.81	-371.35	-203.98	-14.99

Competitive Comparison of Immunovia AB's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Immunovia AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immunovia AB's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Immunovia AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Immunovia AB's ROE % Adjusted to Book Value falls into.

Immunovia AB ROE % Adjusted to Book Value Calculation

Immunovia AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-199.13%	/	1.20
	=	-165.94%

Immunovia AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-21.29%	/	1.42
	=	-14.99%

Immunovia AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Immunovia AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunovia AB (OSTO:IMMNOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Immunovia AB (OSTO:IMMNOV) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

IMMVF:USA

Address

Medicon Village, Scheelevagen 8, Lund, SWE, 223 63

Website

https://www.immunovia.com

Immunovia AB molecular diagnostic company. It develops and commercializes diagnostic tools for complex forms of cancer and autoimmune diseases. Its technology platform IMMray (TM), is based on antibody microarray analysis. The group's intangible and tangible assets are in Sweden, in the United States and in Germany.

Immunovia AB (OSTO:IMMNOV) Headlines

No Headlines